CVI Investments, Inc. 13D and 13G filings for Silexion Therapeutics Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-12 12:12 pm Purchase |
2025-03-31 | 13G | Silexion Therapeutics Ltd. SLXN |
CVI Investments, Inc. | 456,531 4.900% |
117,531 (+34.67%) |
Filing |
| 2025-01-23 12:19 pm Purchase |
2025-01-15 | 13G | Silexion Therapeutics Ltd. SLXN |
CVI Investments, Inc. | 339,000 8.500% |
339,000 (New Position) |
Filing |